WA
MDT icon

Win Advisors’s Medtronic MDT Stock Holding History

Win Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,107
Closed -$998K – 70
2025
Q1 		$998K Buy
+11,107
New +$994K 0.51% 33
2022
Q4 		– Sell
-201
Closed -$16K – 151
2022
Q3 		$16K Sell
201
-2
-1% -$180 0.01% 76
2022
Q2 		$19K Buy
203
+68
+50% +$6.89K 0.04% 86
2022
Q1 		$15K Buy
+135
New +$14.3K ﹤0.01% 124

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Win Advisors's MDT Position: Q2 2025 in Review

Win Advisors sold out of Medtronic (MDT) in Q2 2025, closing a stake of 11,107 shares — an estimated $998K sold.

Win Advisors first reported a position in MDT in Q1 2022 and held it in 4 quarters. The position peaked at $998K in Q1 2025. 2,145 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • Win Advisors reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
  • Win Advisors sold 11,107 Medtronic shares in Q2 2025, an estimated $998K.
  • Win Advisors first reported a position in Medtronic in Q1 2022 and held it in 4 quarters.
  • Win Advisors's Medtronic position peaked at $998K in Q1 2025.
  • 2,145 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Win Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.